Aspirin in primary prevention. Risks and benefits. Up date 2019. A meta-analysis

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Lorenzo Martin Lobo

Education Administration - Argentine Army, Buenos Aires (Argentina)

12 More presentations in this session

Presentation thumbnail

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Doctor I. Hammami (Oxford, GB)

Presentation thumbnail

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

Doctor A. Conti (Massa, IT)

Abstract Slides

Presentation thumbnail

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

Doctor A. Baluja (Santiago de Compostela, ES)

Abstract Slides

Presentation thumbnail

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Doctor A. Katbeh (Damascus, SY)

Abstract Slides

Presentation thumbnail

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Professor D. Linz (Maastricht, NL)

Access the full session

Session thumbnail

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources